Clinical Trials

29 enrolled

Neuroendocrine Tumors

NCT00107289 2026-03-13

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

200 enrolled

Neuroblastoma, Pheochromocytoma

NCT06353529 2026-03-12

POPPY

Phase 4 Recruiting

108 enrolled

Pain, Postoperative, Pituitary Diseases

NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

133 enrolled

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

NCT03753919 2026-03-11

DUTHY

Phase 2 Terminated

79 enrolled 25 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT02402920 2026-03-10

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Phase 1 Completed

83 enrolled 13 charts

Phase NA Active not recruiting

Neuroendocrine Tumors

NCT04175678 2026-03-10

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

100 enrolled

EndocrineOther

Motor Activity, Obesity, Multiple Endocrine Neoplasia Type 1

NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Phase EARLY_PHASE1 Not yet recruiting

50 enrolled

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT06957691 2026-03-09

Fezo-ADT

60 enrolled

EndocrineGenitourinary

Adenocarcinoma, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT07456878 2026-03-09

Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas

Phase 1 Recruiting

5 enrolled

Pituitary Neoplasms

NCT07458906 2026-03-09

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

60 enrolled

Carcinoma, Neuroendocrine

NCT05918302 2026-03-06

LEVEL

Phase 3 Recruiting

120 enrolled

Thymus Neoplasms, Neuroendocrine Tumors

NCT05988918 2026-03-06

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

EndocrineGastrointestinalNET

66 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell, Somatostatinoma, Carcinoma, Adenosquamous

NCT05604963 2026-03-05

HoT

456 enrolled

Phase 1/2 Not yet recruiting

Differentiated Thyroid Cancer

NCT07453225 2026-03-05

Empirical Radioactive Iodine Therapy in DTC

100 enrolled

Differentiated Thyroid Cancer

NCT06295952 2026-03-04

A Study of Pasireotide in People With Prolactinoma

10 enrolled

EndocrineGastrointestinalThoracic

Prolactin-Producing Pituitary Tumor

NCT04785287 2026-03-03

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Phase 1/2 Terminated

13 enrolled

Adrenal Gland Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT03211988 2026-03-02

Entinostat Neuroendocrine (NE) Tumor

Phase 2 Terminated

5 enrolled 9 charts

Recurrence, Neuroendocrine Tumors

NCT03946527 2026-03-02

LAMPARA

10 enrolled

Paraganglioma, Pheochromocytoma

NCT04321954 2026-02-27

Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Differentiated Thyroid Cancer

NCT04969887 2026-02-27

MOST-CIRCUIT

240 enrolled

Phase EARLY_PHASE1 Recruiting

Genital Neoplasms, Female, Neuroendocrine Tumors

NCT05636540 2026-02-27

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Phase 2/3 Not yet recruiting

Paraganglioma, Pheochromocytoma

NCT07440290 2026-02-27

DETERMINE

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT03416686 2026-02-25

METATHYRAF

Phase NA Active not recruiting

14 enrolled

Differentiated Thyroid Cancer

NCT07068542 2026-02-24

TROPION

94 enrolled

Thyroid Carcinoma, Anaplastic

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

EndocrineGastrointestinalNET

360 enrolled

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT04675710 2026-02-19

Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer

Phase EARLY_PHASE1 Active not recruiting

Thyroid Carcinoma, Anaplastic

NCT04993261 2026-02-19

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

71 enrolled

Phase 1 Not yet recruiting

Carcinoid Tumor, Serotonin Syndrome

NCT06941480 2026-02-19

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

12 enrolled

BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Carcinoma, Neuroendocrine

NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Phase 1/2 Suspended

29 enrolled

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06006013 2026-02-18

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

21 enrolled

Adrenal Cortex Neoplasms, Adrenocortical Carcinoma

NCT04278118 2026-02-17

HiPPI

70 enrolled

Phase 3 Not yet recruiting

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT06822751 2026-02-17

FOMUTI

138 enrolled

Cystitis, Prostatitis, Urinary Tract Infections, Multiple Endocrine Neoplasia Type 1

NCT07412782 2026-02-17

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

100 enrolled

EndocrineOther

Bone Diseases, Metabolic, Cushing Syndrome, Dwarfism, Pituitary, Neoplasms, Obesity, Osteogenesis Imperfecta, Osteoporosis, Malnutrition, Overweight

NCT02143726 2026-02-11

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer

35 enrolled 14 charts

Thyroid cancer, Hurthle cell

NCT06937905 2026-02-11

TARLANEC

Phase 3 Recruiting

129 enrolled

Carcinoma, Neuroendocrine

NCT04706910 2026-02-09

18F-DOPA II - PET Imaging Optimization

Phase 3 Recruiting

800 enrolled

CNSEndocrineNET

Brain Neoplasms, Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Lewy Body Disease, Congenital Hyperinsulinism

NCT05139277 2026-02-06

Evaluation of the CONVIVO System

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neurilemmoma, Pituitary Neoplasms

NCT04104529 2026-02-05

BCB RIV